长按二维码,关注官方公众号
You can share it to WeChat via the Qr code.
Enter the applet sharing event using WeChat scan.
Welcome Speech
The Latest Policy and Development Trend of Medical Reform
The Impact of the STAR Market on the Bio-Pharmaceutical Industry
Tea Break
Panel Discussion: Balancing the Price and Market under 4+7
Development Strategy for Long-released Injectable Preparations
Research and Application of Long-acting Nanocrystalline Injection
Tea Break
Prospects of Drugs for International Market Development
Panel Discussion: Innovative and Improved Formulation R&D and Patent Strategy
Improve the Related Review System to Ensure the Quality and Safety of Drugs
Study on the Selection and Stability of Drug Polymorphs
Analysis Control and Risk Assessment of Impurities in ICH M7
Tea Break
Complex Injection Consistency Evaluation Research and Case Study
Injection Development Ideas and High-risk Control
Interpretation of ICH M10: Bioanalytical Method Validation Final endorsed Business Plan
Tea Break
Factors and Process of Pellets Formulation
The Application of Oral Sustained-Release Drug Delivery System in Neurological Dugs
Tea Break
Difficulties in Analysis of the Pre-formulation Design of Oral Sustained-release Preparations
Practical Considerations for the Development of New Drug Products via 505b(2) NDA Pathway
Luncheon
Panel Discussion: How to Improve the Stability of Sustained-release Injection?
R&D and Recent Progress of Pharmaceutical Preparations
Tea Break
BioBAY- the First Choice for Innovative Biomedical Industrialization
Treatment Dilemma and New Drug Innovation for Central Nervous System Diseases
Strategy and Consideration of Formulation about Novel Drugs on Different Stages
Deep Interpretation of the Current Situation and Prospect of eCTD Implementation in China
Strategies of Registration with eCTD
Tea Break
Panel Discussion: Common Issues in the Submission of Registration Applications with eCTD
Luncheon
Panel Discussion：Common Problems and Strategies of the Registration in Domestic Regulations
Declaration and Capacity Building under MAH
Research and Development Strategy of Generics ANDA in US
Tea Break
Consistency Evaluation and Technical Guidance of Sustained-release Preparations and Reference Preparations
Thoughts on the Consistency Evaluation of Generics Scientifically
Tea Break
Mistakes in BE Trial of Generic Drugs
Panel Discussion: Consistency Evaluation of Quality and Efficiency of Poorly Soluble Preparation
Luncheon
Bioequivalence Test and Consistency Evaluation of High Variation Drugs
Bioequivalence Research and Technical Challenges in Inhalations
Analysis of the Main Points of Evaluation of Internal and External Consistency of Slow Control Agent
Tea Break
Welcome Speech
The Latest Policy and Development Trend of Medical Reform
The Impact of the STAR Market on the Bio-Pharmaceutical Industry
Tea Break
Panel Discussion: Balancing the Price and Market under 4+7
Development Strategy for Long-released Injectable Preparations
Research and Application of Long-acting Nanocrystalline Injection
Tea Break
Prospects of Drugs for International Market Development
Panel Discussion: Innovative and Improved Formulation R&D and Patent Strategy
Improve the Related Review System to Ensure the Quality and Safety of Drugs
Study on the Selection and Stability of Drug Polymorphs
Analysis Control and Risk Assessment of Impurities in ICH M7
Tea Break
Complex Injection Consistency Evaluation Research and Case Study
Injection Development Ideas and High-risk Control
Interpretation of ICH M10: Bioanalytical Method Validation Final endorsed Business Plan
Tea Break
Factors and Process of Pellets Formulation
The Application of Oral Sustained-Release Drug Delivery System in Neurological Dugs
Tea Break
Difficulties in Analysis of the Pre-formulation Design of Oral Sustained-release Preparations
Practical Considerations for the Development of New Drug Products via 505b(2) NDA Pathway
Luncheon
Panel Discussion: How to Improve the Stability of Sustained-release Injection?
R&D and Recent Progress of Pharmaceutical Preparations
Tea Break
BioBAY- the First Choice for Innovative Biomedical Industrialization
Treatment Dilemma and New Drug Innovation for Central Nervous System Diseases
Strategy and Consideration of Formulation about Novel Drugs on Different Stages
Deep Interpretation of the Current Situation and Prospect of eCTD Implementation in China
Strategies of Registration with eCTD
Tea Break
Panel Discussion: Common Issues in the Submission of Registration Applications with eCTD
Luncheon
Panel Discussion：Common Problems and Strategies of the Registration in Domestic Regulations
Declaration and Capacity Building under MAH
Research and Development Strategy of Generics ANDA in US
Tea Break
Consistency Evaluation and Technical Guidance of Sustained-release Preparations and Reference Preparations
Thoughts on the Consistency Evaluation of Generics Scientifically
Tea Break
Mistakes in BE Trial of Generic Drugs
Panel Discussion: Consistency Evaluation of Quality and Efficiency of Poorly Soluble Preparation
Luncheon
Bioequivalence Test and Consistency Evaluation of High Variation Drugs
Bioequivalence Research and Technical Challenges in Inhalations
Analysis of the Main Points of Evaluation of Internal and External Consistency of Slow Control Agent
Tea Break
